Biocon informs about media release

08 Apr 2026 Evaluate

Biocon has informed that it enclosed Company Statement with respect to ‘Biocon Pharma Limited Receives U.S. FDA Approval for Dapagliflozin Tablets, 5 mg and 10 mg’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

350.00 9.85 (2.90%)
08-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1713.60
Dr. Reddys Lab 1191.45
Cipla 1215.80
Zydus Lifesciences 891.55
Lupin 2293.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×